44 related articles for article (PubMed ID: 788293)
1. Second generation androgen receptor antagonists and challenges in prostate cancer treatment.
Chen Y; Zhou Q; Hankey W; Fang X; Yuan F
Cell Death Dis; 2022 Jul; 13(7):632. PubMed ID: 35864113
[TBL] [Abstract][Full Text] [Related]
2. An Overview of Next-Generation Androgen Receptor-Targeted Therapeutics in Development for the Treatment of Prostate Cancer.
Mohler ML; Sikdar A; Ponnusamy S; Hwang DJ; He Y; Miller DD; Narayanan R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672769
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer.
Narayanan R
Asian J Urol; 2020 Jul; 7(3):271-283. PubMed ID: 32742927
[TBL] [Abstract][Full Text] [Related]
4. Synergic development of pharmacokinetics and bioanalytical methods as support of pharmaceutical research.
Marzo M; Ciccarelli R; Di Iorio P; Giuliani P; Caciagli F; Marzo A
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):168-79. PubMed ID: 26684641
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.
Kunath F; Grobe HR; Rücker G; Motschall E; Antes G; Dahm P; Wullich B; Meerpohl JJ
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009266. PubMed ID: 24979481
[TBL] [Abstract][Full Text] [Related]
6. Hormonal therapy for stage D cancer of the prostate.
Gudziak MR; Smith AY
West J Med; 1994 Apr; 160(4):351-9. PubMed ID: 8023485
[TBL] [Abstract][Full Text] [Related]
7. Endocrine treatment of prostatic cancer.
Williams G
J R Soc Med; 1985 Oct; 78(10):797-9. PubMed ID: 4045880
[No Abstract] [Full Text] [Related]
8. The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment.
Schulz M; Schmoldt A; Donn F; Becker H
Eur J Clin Pharmacol; 1988; 34(6):633-6. PubMed ID: 3169114
[TBL] [Abstract][Full Text] [Related]
9. Flutamide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer.
Brogden RN; Clissold SP
Drugs; 1989 Aug; 38(2):185-203. PubMed ID: 2670515
[TBL] [Abstract][Full Text] [Related]
10. Flutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in advanced prostatic cancer.
Brogden RN; Chrisp P
Drugs Aging; 1991 Mar; 1(2):104-15. PubMed ID: 1794008
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the treatment of genitourinary tract disorders in the older individual.
Atala A; Amin M
Drugs Aging; 1991 May; 1(3):176-93. PubMed ID: 1724398
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced prostatic cancer with flutamide.
Sanford EJ; Bowditch RR; Rohner TJ; Bardin CW
Pa Med; 1979 Sep; 82(9):29-31. PubMed ID: 386212
[No Abstract] [Full Text] [Related]
13. Flutamide versus stilboestrol in the management of advanced prostatic cancer. A controlled prospective study.
Lund F; Rasmussen F
Br J Urol; 1988 Feb; 61(2):140-2. PubMed ID: 3280080
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for pure antiandrogens in the treatment of advanced prostatic cancer?
Pavone-Macaluso M; Serretta V; Daricello G; Pavone C; Cacciatore M; Romano C; Cavallo N
Prog Clin Biol Res; 1990; 350():149-57. PubMed ID: 2201041
[TBL] [Abstract][Full Text] [Related]
15. The use of flutamide as monotherapy in the treatment of advanced prostate cancer.
Newling DW
Prog Clin Biol Res; 1989; 303():117-21. PubMed ID: 2674980
[No Abstract] [Full Text] [Related]
16. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer.
Jacobo E; Schmidt JD; Weinstein SH; Flocks RH
Urology; 1976 Sep; 8(3):231-3. PubMed ID: 788293
[TBL] [Abstract][Full Text] [Related]
17. Flutamide therapy for carcinoma of the prostate.
Airhart RA; Barnett TF; Sullivan JW; Levine RL; Schlegel JU
South Med J; 1978 Jul; 71(7):798-801. PubMed ID: 78529
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
